Akkermansia muciniphila in Metabolic Disease: Far from Perfect
International Journal of Molecular Sciences · 29.11.2025 · 26 (23) · 11602
DOI: 10.3390/ijms262311602 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.11.2025. Verfasst von Oana Laura Mierlan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania. Hauptthemen laut MEDLINE: Metabolic Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The root of metabolic disease lies in the gastrointestinal tract, where nutrient absorption occurs. Within this environment, a diverse community of microorganisms exerts effects that extend beyond the intestinal barrier. Akkermansia muciniphila (A. muciniphila), one such bacterium, has been associated with enhanced intestinal integrity, reduced intestinal inflammation, weight loss, and improved insulin sensitivity, mediated through mucus fermentation, production of short-chain fatty acids (SCFAs), bacterial proteins, and extracellular vesicles (EVs). Research in this field is promising, yet far from perfect. Its clinical applicability remains limited by factors such as strain variability, scarcity of human intervention studies, and the lack of established causality. While associations have been consistently observed in both rodent and human studies, causality has thus far been demonstrated only in animal models. This issue is of critical importance, as metabolic disease remains highly prevalent, carries systemic consequences, and imposes a substantial burden on healthcare systems, underscoring the urgent need for alternative therapeutic strategies. The aim of this narrative review is to synthesize current knowledge on A. muciniphila and to highlight the key limitations consistently reported in the literature. By addressing these factors, the review seeks to provide realistic perspectives on its therapeutic potential and to outline directions for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
- "Sf. Ioan" Emergency Clinical Pediatric Hospital, 800487 Galati, Romania.
- "Sf. Andrei" Clinical Emergency County Hospital, 800578 Galati, Romania.
- Center for Research and Technology Transfer in the Medico-Pharmaceutical Field, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
ORCID-Profile: Oana Laura Mierlan, Octavian Amaritei, Cosmin Raducu Raileanu, Nicoleta-Maricica Maftei, Gabriela Gurau
Zitieren
APA
Mierlan, O. L., Busila, C., Amaritei, O., Elena, D., Raileanu, C. R., Maftei, N. M., Matei, M. N., & Gurau, G. (2025). Akkermansia muciniphila in Metabolic Disease: Far from Perfect. International Journal of Molecular Sciences, 26(23), 11602. https://doi.org/10.3390/ijms262311602
Vancouver
Mierlan OL, Busila C, Amaritei O, Elena D, Raileanu CR, Maftei NM, et al. Akkermansia muciniphila in Metabolic Disease: Far from Perfect. International Journal of Molecular Sciences. 2025;26(23):11602. doi:10.3390/ijms262311602
BibTeX
@article{Mierlan2025,
author = {Mierlan, Oana Laura and Busila, Camelia and Amaritei, Octavian and Elena, Dogaru and Raileanu, Cosmin Raducu and Maftei, Nicoleta-Maricica and Matei, Madalina Nicoleta and Gurau, Gabriela},
title = {Akkermansia muciniphila in Metabolic Disease: Far from Perfect},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {23},
pages = {11602},
doi = {10.3390/ijms262311602}
}
EUVIMED